The "Physical AI" Monopoly – A New Industrial Revolution

Tesla is positioning itself as more than a car company, with robots and AI services becoming central to its long-term vision. The idea is that software and robotics could eventually generate recurring revenue far beyond vehicle sales. For investors, Tesla represents a bold bet on a future where AI and robotics reshape entire industries, with volatility as the price of admission.

Fair Value

~37% undervalued vs current price

💡 Why we like it: The author explains Tesla through a familiar Apple-style lens, using an ecosystem story most investors already understand. That comparison makes a complex idea click quickly, while offering a far more nuanced view of Tesla than the usual media noise.

Czechoslovak Group - is it really so hot?

CSG has arrived on public markets at a time when European defense spending is rising sharply. The company is a major producer of ammunition, an area where supply is tight and hard to expand quickly. While a sudden end to the war in Ukraine would likely hurt sentiment, Europe would still need to rebuild depleted stockpiles. For investors, CSG offers exposure to long-term defense spending, with higher sensitivity to geopolitical shifts than more diversified peers.

Fair Value

~42% undervalued vs current price

💡 Why we like it: You can tell this is written by someone who actually knows the region. The author adds real local color – politics, regulation, economics, even public – that you just don’t get from a standard, numbers-only analysis, making the story feel far more grounded and credible.

The Compound Effect: From Acquisition to Integration

Swedencare’s story is no longer about buying more pet health brands, but about making the ones it owns work harder. Management is pushing its core products into big retail chains and bringing more sales in-house to improve control and margins. The recent dip in profitability reflects heavy investment rather than a broken business. If margins recover as expected, Swedencare could regain investor confidence as a long-term growth compounder in pet care.

Fair Value

~48% undervalued vs current price

💡 Why we like it: This one moves past flashy acquisition headlines and gets into the part that actually matters – execution. It’s a clear, thoughtful walk-through of how growth stories succeed or fail after the deals are done, which makes it especially useful for patient investors.

Was this email useful?